These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 20656347

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury.
    Kang CE, Baumann MD, Tator CH, Shoichet MS.
    Cells Tissues Organs; 2013; 197(1):55-63. PubMed ID: 22796886
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord.
    Gupta D, Tator CH, Shoichet MS.
    Biomaterials; 2006 Apr; 27(11):2370-9. PubMed ID: 16325904
    [Abstract] [Full Text] [Related]

  • 5. Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel.
    Stanwick JC, Baumann MD, Shoichet MS.
    J Control Release; 2012 Jun 28; 160(3):666-75. PubMed ID: 22510446
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system.
    Kang CE, Tator CH, Shoichet MS.
    J Control Release; 2010 May 21; 144(1):25-31. PubMed ID: 20114065
    [Abstract] [Full Text] [Related]

  • 8. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection.
    Tsai EC, Dalton PD, Shoichet MS, Tator CH.
    Biomaterials; 2006 Jan 21; 27(3):519-33. PubMed ID: 16099035
    [Abstract] [Full Text] [Related]

  • 9. Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury.
    Wang YC, Wu YT, Huang HY, Lin HI, Lo LW, Tzeng SF, Yang CS.
    Biomaterials; 2008 Dec 21; 29(34):4546-53. PubMed ID: 18774604
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW, Tegnell E, Toporek SS, Reichert WM.
    Biomaterials; 2005 Jun 21; 26(16):3285-97. PubMed ID: 15603824
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord.
    Shoichet MS, Tator CH, Poon P, Kang C, Baumann MD.
    Prog Brain Res; 2007 Jun 21; 161():385-92. PubMed ID: 17618992
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord.
    Elliott Donaghue I, Tator CH, Shoichet MS.
    Biomater Sci; 2015 Jan 21; 3(1):65-72. PubMed ID: 26214190
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.